Name | Pateclizumab |
---|
Description | Pateclizumab (MLTA3698A) is a humanized antibody against lymphotoxin α (LTα), a transiently expressed cytokine on activated B and T cells (Th1, Th17), which are implicated in rheumatoid arthritis (RA) pathogenesis[1]. |
---|---|
Related Catalog | |
Target |
lymphotoxin α |
References |
No Any Chemical & Physical Properties |